Clinical trial

Islet Transplantation for Type 1 Diabetes

NCT00014911

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-04-01

PhasePHASE2

Study timeline

Study start (unknown)2001-04-01Date precision: month

Registry last updated2017-03-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Insulin-Dependentunresolved

Interventions

Islet TransplantationPROCEDURE

SirolimusDRUG · verified · RxNorm: sirolimus

TacrolimusDRUG · verified · RxNorm: tacrolimus

SulfamethoxazoleDRUG · verified · RxNorm: sulfamethoxazole

GanciclovirDRUG · verified · RxNorm: ganciclovir

TrimethoprimDRUG · verified · RxNorm: trimethoprim

PentamidineDRUG · verified · RxNorm: pentamidine

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Immune Tolerance Network (ITN)collaborator

Mapped research locations

BostonMassachusetts, United States1 St LouisMissouri, United States1 MiamiFlorida, United States1 SeattleWashington, United States1 MinneapolisMinnesota, United States1 MilanItaly1 EdmontonAlberta, Canada1 GenevaSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00014911 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.